Vestcor Inc Sells 7,543 Shares of Maximus, Inc. (NYSE:MMS)

Vestcor Inc lowered its stake in Maximus, Inc. (NYSE:MMS) by 43.9% during the fourth quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 9,654 shares of the health services provider’s stock after selling 7,543 shares during the quarter. Vestcor Inc’s holdings in Maximus were worth $721,000 as of its most recent SEC filing.

A number of other hedge funds and other institutional investors have also modified their holdings of the stock. Avantax Advisory Services Inc. increased its position in shares of Maximus by 4.8% in the fourth quarter. Avantax Advisory Services Inc. now owns 19,097 shares of the health services provider’s stock valued at $1,426,000 after acquiring an additional 869 shares during the last quarter. Farther Finance Advisors LLC increased its position in shares of Maximus by 109.2% in the fourth quarter. Farther Finance Advisors LLC now owns 820 shares of the health services provider’s stock valued at $61,000 after acquiring an additional 428 shares during the last quarter. Inspire Advisors LLC increased its position in shares of Maximus by 3.1% in the fourth quarter. Inspire Advisors LLC now owns 8,650 shares of the health services provider’s stock valued at $646,000 after acquiring an additional 258 shares during the last quarter. Zurcher Kantonalbank Zurich Cantonalbank increased its position in shares of Maximus by 19.0% in the fourth quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 15,413 shares of the health services provider’s stock valued at $1,151,000 after acquiring an additional 2,464 shares during the last quarter. Finally, Ruffer LLP acquired a new stake in shares of Maximus in the fourth quarter valued at about $10,266,000. Institutional investors and hedge funds own 97.21% of the company’s stock.

Maximus Price Performance

Shares of NYSE MMS opened at $67.06 on Monday. The business’s 50 day moving average price is $72.01 and its two-hundred day moving average price is $79.30. The company has a market cap of $3.80 billion, a PE ratio of 14.42 and a beta of 0.71. The company has a quick ratio of 1.72, a current ratio of 1.72 and a debt-to-equity ratio of 0.82. Maximus, Inc. has a twelve month low of $63.77 and a twelve month high of $93.97.

Maximus (NYSE:MMS) last announced its quarterly earnings results on Thursday, February 6th. The health services provider reported $1.61 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.22. Maximus had a return on equity of 21.95% and a net margin of 5.28%. On average, analysts predict that Maximus, Inc. will post 6.15 EPS for the current year.

Maximus Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Friday, February 28th. Stockholders of record on Saturday, February 15th were given a $0.30 dividend. This represents a $1.20 annualized dividend and a dividend yield of 1.79%. The ex-dividend date of this dividend was Friday, February 14th. Maximus’s payout ratio is 25.81%.

Analyst Upgrades and Downgrades

MMS has been the topic of a number of recent research reports. StockNews.com downgraded Maximus from a “buy” rating to a “hold” rating in a research report on Friday, February 14th. Raymond James raised Maximus from a “market perform” rating to an “outperform” rating and set a $90.00 price target on the stock in a research report on Thursday, January 2nd.

Insider Activity

In other news, CEO Bruce Caswell bought 3,500 shares of the firm’s stock in a transaction dated Tuesday, December 17th. The shares were bought at an average price of $70.64 per share, with a total value of $247,240.00. Following the completion of the transaction, the chief executive officer now owns 275,929 shares of the company’s stock, valued at $19,491,624.56. This trade represents a 1.28 % increase in their ownership of the stock. The purchase was disclosed in a filing with the SEC, which is accessible through the SEC website. Also, insider Ilene R. Baylinson sold 14,500 shares of the company’s stock in a transaction that occurred on Wednesday, February 19th. The shares were sold at an average price of $68.14, for a total value of $988,030.00. Following the completion of the transaction, the insider now directly owns 2,512 shares in the company, valued at $171,167.68. The trade was a 85.23 % decrease in their position. The disclosure for this sale can be found here. 1.60% of the stock is owned by company insiders.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.